Teva reports a net loss for its second quarter

[anonymous]

Teva posted an 18% decline in revenues along with a net loss for its second quarter. Revenues dropped mainly due to Copaxone.

https://news.alphastreet.com/teva-pharmaceuticals-earnings-q2-2018/